The largest database of trusted experimental protocols

4oh tmx

Manufactured by Merck Group

4OH-TMX is a chemical compound used in various laboratory research applications. It serves as a core functional component in specific experimental procedures, but a detailed description of its intended use would require further information that is not available in this context.

Automatically generated - may contain errors

7 protocols using 4oh tmx

1

Evaluating Novel Cancer Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
RITA (NSC652287) was obtained from the National Cancer Institute (NCI). NSC777196 and NSC782846 were a generous gift from Dr Peter Wipf. DMSO, ActD, 4OH-TMX and Nutlin-3 were purchased from Sigma-Aldrich. The compound concentrations and durations of treatment are mentioned in the figure legends.
+ Open protocol
+ Expand
2

Tracheosphere Formation and Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Epithelial cells from wild-type mice were used to induce tracheospheres formation. After 10 days, Rapamycin (final concentration 200nM, LC Laboratories) or EtOH 100% (control) was added to the MTEC/SF for 6 days. Medium was changed every day.
For TSC1 KO recombination in culture, epithelial cells from Krt5-Cre Rosa26R-LacZ with or without TSC1 fl/fl were used to induce spheres formation. After 9 days, 4-OH-Tmx (final concentration 300nM, Sigma) or EtOH 100% (control) was added to the MTEC/SF for 48h.
Then tracheospheres were fixed with 4% paraformaldehyde in PBS, stained and imaged as described above for whole trachea. Antibody used to detect cleaved Caspase-3 was rabbit anti-cleaved Casp3, 1:400 (#9661, Cell Signaling).
+ Open protocol
+ Expand
3

Cytotoxic Compounds Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
RITA (NSC652287) was obtained from the NCI. NSC777196 and NSC782846 were a generous gift from Dr. P. Wipf. DMSO, ActD (actinomycin D), 4OH-TMX and Nutlin-3 were purchased from Sigma-Aldrich. The compound concentrations and durations of treatment are mentioned in the figure legends.
+ Open protocol
+ Expand
4

Characterizing Tumor Cell Responses to Antineoplastic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
RITA (NSC652287) and aminoflavone (NSC686288) were obtained from the National Cancer Institute (NCI), oncrasin-1 was from Santa Cruz Biotechnology, and 4OH-TMX and resveratrol were purchased from Sigma-Aldrich. We have tested different concentrations of 4OH-TMX (from 10 nM to 1 μM) in ex vivo samples and from 100 nM to 6 μM range of concentrations in MCF7 cells in a short-term viability experiment. The concentration of 4OH-TMX which we used is consistent with several reports in which 4OH-TMX was used in a short-term experiment [23 (link)–25 (link)]. The TMX-resistant MCF7-LCC2 cells were treated with ≥1 μM 4OH-TMX. The compound concentrations and durations of treatment are mentioned in the figure legends.
+ Open protocol
+ Expand
5

Conditional Embryonic Development Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
E10.5 Sptlc2f/fCdh5CreERT2/+ embryos were harvested, washed once with pre-warmed PBS, placed in DMEM-F12 media (Thermo Fisher) supplemented with 5% FBS and equilibrated in 37°C incubator with 5% CO2. The extra-embryonic tissues were removed using a dissection microscope. Embryos were divided in two groups. The experimental group was cultured in embryo culture medium containing DMEM-F12 (Thermo Fisher), 15% KSR (Thermo Fisher), 1x N2 supplement (Thermo Fisher), 1x Glutamax (Thermo Fisher), 2.5 µL/mL of 100x Pen-Strep solution (Thermo Fisher), 1 µM 4-OH-TMX (Sigma), 5 µM D-erythroSO-BSA complexes and 25 nM 1-deoxySO-BSA complexes. Control group embryos were cultured similarly but received vehicle-BSA complexes in place of 1-deoxySO-BSA complexes. Cultures were carried out in 50 mL conical tubes in high O2 atmosphere which was created by attaching a Steriflip filter unit (Millipore Sigma) connected to an O2 tank for 20–30 sec. The tubes were sealed with parafilm and placed in roller bottle in a 37°C incubator with 5% CO2 for 24 hours. The embryos were then washed in PBS with Ca+2 and Mg+2 (Thermo Fisher) and fixed overnight in Ca+2Mg+2 PBS plus 0.4% PFA (Electron Microscopy Sciences 15710). The fixed embryos were washed with PBS and stored in PBS plus 0.1% Sodium Azide. Embryos were genotyped and processed for light sheet microscopy as described above.
+ Open protocol
+ Expand
6

Conditional Kidney V2R Disruption

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments carried out were approved by the Institutional Committee on Research Animal Care, in accordance with the Italian Institute of Health Guide for the Care and Use of Laboratory Animals.
Mice were maintained on a 12-h light/12-h dark cycle, with free access to water and food.
Wt C57BL/6 mice (Harlan Laboratories (Indianapolis, IN), males, 8-week old) were used to obtain kidney slices.
The generation of conditional V2R mutant mice (V2Rfl/fland V2Rfl/yEsr1-Cre mice) has been described previously.15 (link) To disrupt the V2R gene in V2Rfl/yEsr1-Cre mice and to induce the X-NDI phenotype, a stock solution of 4OH-TMX (Sigma), prepared in preheated ethanol (50 mg/ml), was diluted in corn oil to 5 mg/ml. Adult V2Rfl/yEsr1-Cre mice (age 7–8 weeks old) were given a daily i.p. injection of 4-OH-TMX (0.1 ml of a 5 mg/ml suspension) over 6 days.
+ Open protocol
+ Expand
7

Culturing Muscle Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MuSCs were cultured in growth medium (DMEM supplemented with 30% foetal bovine serum (Sigma-Aldrich), 1% chicken embryo extract (US Biological), 10 ng/ml basic fibroblast growth factor (ORIENTAL YEAST Co., Ltd.), and 1% penicillin–streptomycin (FUJIFILM Wako Pure Chemical Corporation)) on culture dishes coated with Matrigel (Corning). 4-OH TMX (1 μM; Sigma-Aldrich) was added to both control and Piezo1 cKO growth medium for freshly isolated MuSC culture. The reagents BAPTA-AM (20 μM; Dojindo) and EdU (10 μM; Life Technologies) were added to the growth medium during culturing. Rho activator II (CN03; Cytoskeleton, Inc.) was added to the growth medium 24 h after plating.
For MuSC growth on floating myofibres, isolated myofibres were cultured in plating medium (DMEM supplemented with 10% horse serum (Gibco), 0.5% chick embryo extract, and 1% penicillin–streptomycin) at 37°C with 5% CO2. Next, 5 μM EdU (Life Technologies) was added to the plating medium to analyse S-phase entry. Rho activator II (CN03; Cytoskeleton, Inc.) or Rho inhibitor I (CT04; Cytoskeleton, Inc.) was added to the plating medium at indicated time points shown in Figs 7F and I and S9C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!